VR Logo

Gufic Biosciences Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1984

Chairman: Jayesh P Choksi

Managing Director: Jayesh P Choksi

Group: --

Listing: NSE: GUFICBIO, BSE: 509079

Headquarters: Mumbai, Maharashtra

Website: www.gufic.com

Key Facts

Market cap: R 915.28 Cr

Revenue (TTM): R 353.83 Cr

Earnings (TTM): R 24.33 Cr

Cash: R 10.82 Cr

Total Debt: R 110.73 Cr

Promoters' ownership: 65.75%

Liquidity: High

52 Week range: R 37.00 - 137.45

Face value: R1.00

Shares outstanding: 7,78,30,000

10 Years Aggregate:

  • CFO: 71.12 Cr
  • EBITDA: 222.50 Cr
  • Net Profit: 92.36 Cr

Stock Performance

Time Period Gufic Biosciences S&P BSE Healthcare S&P BSE Small Cap
YTD0.56-1.601.79
1 month3.201.417.62
3 months31.108.4622.58
1 Year90.8852.3525.89
3 Years-2.6412.53-2.06
5 Years25.526.5311.68
10 Years34.3012.557.48
As on 22-Jan-2021
Year Gufic Biosciences S&P BSE Small Cap S&P BSE Healthcare
202093.4732.1161.45
2019-35.40-6.85-3.55
2018-26.15-23.41-5.89
2017138.2559.640.49
2016-4.491.77-12.88
2015225.156.7615.06